MALAT1 and cancer: To investigate whether CricNOTCH1 and/or lncRNA MALAT1 regulate xCT expression via miR-34c modulation, affecting cancer phenotypes such as drug resistance, we performed systematic gain-of-function (GoF) and loss-of-function (LoF) perturbations.